<DOC>
	<DOCNO>NCT00002091</DOCNO>
	<brief_summary>PRIMARY : To determine whether pentoxifylline change self-reported measure quality life status , use measure score double-blinded drug withdrawal drug restart period . SECONDARY : To measure change monthly CD4 count , fast serum triglyceride level , weight ; ass safety pentoxifylline HIV-infected person .</brief_summary>
	<brief_title>An Evaluation Pentoxifylline HIV-Positive Persons With Symptomatic HIV Infection Karnofsky Score &gt; 40 Percent &lt; 100 Percent</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Stable antiretroviral therapy . Maintenance medication opportunistic infection . Patients must : HIV positivity . NOTE : Patients antiretroviral must receive least 2 month currently perceive need change add regimen next 3 month . Prior Medication : Allowed : Antiviral therapy ( provide patient therapy least 2 month study entry dose stable ) . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Evidence active opportunistic infection malignancy require highdose systemic chemotherapy ( patient 30 day diagnosis opportunistic infection appropriate maintenance medication allow ) . Known significant intolerance hypersensitivity theophylline , theobromine ( chocolate ) , caffeine , reason dyspepsia . Inability swallow tablet ( gastric feeding tube allow ) . Active bleed disorder major bleed source , include peptic ulcer gastritis . Any symptom suggestive concurrent illness attributable overall impairment HIV diagnosable base available evidence . Not willing comply visit schedule study procedure . Concurrent Medication : Excluded : Concurrent use anticoagulant warfarin ( Coumadin ) heparin . Prior Medication : Excluded : Treatment biologic response modifier ( e.g. , interferon , interleukin ) within 14 day prior study entry . Prior Treatment : Excluded : Major surgery within 30 day study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 1993</verification_date>
	<keyword>Pentoxifylline</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
</DOC>